Transitional Cell Carcinoma Due to Chronic UroLume Stent Irritation - 22/08/11
Doi : 10.1016/j.urology.2008.11.039
J. Paddack a, D.E. Leocádio a, ⁎ 
, C. Samathanam b, T. Nelius a, A. Haynes a
, C. Samathanam b, T. Nelius a, A. Haynes a a Department of Urology, Texas Tech University Health Sciences Center, Lubbock, Texas
b Department of Pathology, Texas Tech University Health Sciences Center, Lubbock, Texas
Reprint requests: Dean E. Leocádio, M.D., M.A., Department of Urology, Texas Tech University Health Sciences Center, 3502 9th Street, Suite 260, Lubbock, TX 79415Résumé |
UroLume stents have been used for >15 years to improve the voiding dynamics in patients with benign prostatic hyperplasia and urethral stricture disease. Common complications include stent migration, stricture within the stent, and urothelial hyperplasia, any of which could require stent removal, which itself carries morbidity. We report a case of high-grade urothelial carcinoma associated with chronic UroLume application.
Le texte complet de cet article est disponible en PDF.Plan
© 2009
Elsevier Inc. Tous droits réservés.
Vol 73 - N° 5
P. 995-996 - mai 2009 Retour au numéro
Article précédent
- Empyema of Retained Ureteral Stump With Gross Stone 20 Years After Nephrectomy
- Andrzej Prajsner, Wojciech Szewczyk, Rafal Gawron
- Gastric Diverticulum Mimicking Cystic Lesion in Left Adrenal Gland
- Jose J. Noguera, Alberto Benito, Carmen Hernandez-Sastre, David Cano, Isabel Vivas, Ignacio Gonzalez-Crespo
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?